Increased risk of pneumonia in patients receiving gonadotropin-releasing hormone agonists for prostate cancer.
<h4>Background</h4>This study aimed to investigate the relationship between the use of gonadotropin-releasing hormone (GnRH) agonists and subsequent risk of pneumonia in patients with prostate cancer (PC) using a population-based dataset.<h4>Methods</h4>We obtained the data f...
Guardado en:
Autores principales: | Shiu-Dong Chung, Shih-Ping Liu, Herng-Ching Lin, Li-Hsuan Wang |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Public Library of Science (PLoS)
2014
|
Materias: | |
Acceso en línea: | https://doaj.org/article/ad29902629e042ffbb5493692f2a709c |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
Gonadotropin-releasing hormone agonists sensitize, and resensitize, prostate cancer cells to docetaxel in a p53-dependent manner.
por: Roberta M Moretti, et al.
Publicado: (2014) -
Response to the gonadotropin releasing hormone agonist leuprolide in immature female sheep androgenized in utero
por: RECABARREN,SERGIO E, et al.
Publicado: (2005) -
Abiraterone acetate versus bicalutamide in combination with gonadotropin releasing hormone antagonist therapy for high risk metastatic hormone sensitive prostate cancer
por: Takashi Ueda, et al.
Publicado: (2021) -
Association between prostate cancer and urinary calculi: a population-based study.
por: Shiu-Dong Chung, et al.
Publicado: (2013) -
Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Muzi Li, et al.
Publicado: (2021)